We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy


Teach Me in 10 – Organs-on-a-Chip With Dr Ali Khademhosseini

Video   Sep 24, 2020


This week at Teach Me in 10, we're joined by Dr Ali Khademhosseini, director and CEO of the Terasaki Institute. Formerly, he was Levi Knight Professor of Bioengineering, Chemical Engineering, and Radiology at the University of California-Los Angeles (UCLA). He was the Founding Director of the Center for Minimally Invasive Therapeutics at UCLA.

Khademhosseini is a leader in applying bioengineering solutions to precision medicine. His large and interdisciplinary research group is interested in developing personalized solutions that utilize micro- and nanoscale technologies to enable a range of therapies for organ failure, cardiovascular disease, and cancer. In enabling this vision, he works closely with clinicians (including interventional radiologists, cardiologists and surgeons). Dr Khademhosseini’s has received over 60 major national and international awards. In this installment of Teach Me in 10, he talks us through the concept of organs-on-a-chip, in less than 10 minutes.

Check out the Terasaki Institute's website to learn more about Dr Khademhosseini's interdisciplinary research

Visit the Teach Me in 10 hubpage for the full library of videos published to date. 

More Information

Recommended Videos

Spanish Flu: A Warning From History


To mark the centenary and to highlight vital scientific research, the University of Cambridge made a film exploring what we have learnt about Spanish Flu, the urgent threat posed by influenza today, and how scientists are preparing for future pandemics.


How New Vaccines Are Developed


With the world in the grip of the COVID-19 pandemic, all eyes are on vaccine trials and the researchers developing them. But what are they actually doing?


Harnessing Chemical Biology for Cancer Drug Discovery With Michael Erb


In this Front Row lecture, Assistant Professor Michael Erb will share his research applying chemical tools to study how chromatin, a molecular machine that plays a key role in transcription, becomes disrupted in cancer. He will discuss his research developing small molecule drugs targeting these genetic malfunctions.



Like what you just watched? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free